ElleS Review

Is ElleS worth it?

ElleS built its program around one core idea: compounded GLP-1 (including oral capsules) within a broad telehealth menu. It runs $269/month (12-month plan rate); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option for people who would rather not inject.

Beyond the medication itself, ElleS offers a microdosing option. It also includes coaching or dietitian support and offers NAD+ or peptide add-ons.

How much ElleS costs

Semaglutide runs $269–$299/month depending on plan, the low end a 12-month plan rate, and tirzepatide runs $349–$359/month depending on plan, the low end a 12-month plan rate.

Because ElleS's headline figure is a 12-month plan rate, we don't set it against the roughly $182 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare ElleS with the month-to-month prices of the alternatives below instead.

For a direct comparison, Maximus runs semaglutide and tirzepatide from $249.99/month, so compare it with ElleS before you commit.

Medications: what ElleS prescribes

ElleS prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.

ElleS's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who ElleS is best for, and who should skip it

A good fit if you…

• are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
• want coaching and follow-up built into the price already, instead of sold separately as an upsell.

Look elsewhere if you…

• specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
• need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

ElleS is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.